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This Special Issue of Geneva Papers on Risk and Insurance - Issues and Practice 
contains 10 contributions to the academic literature all dealing with longevity risk and 
capital markets. Draft versions of the papers were presented at Longevity Six: The Sixth 
International Longevity Risk and Capital Markets Solutions Conference that was held in 
Sydney on 9-10 September 2010.  It was hosted by the Australian Institute for Population 
Ageing Research, the Australian School of Business and the University of New South 
Wales. It was sponsored by PricewaterhouseCoopers, Australian Prudential Regulation 
Authority (APRA), Coventry Capital, Swiss Re, and Institute of Actuaries of Australia. 
 
Longevity risk and related capital market solutions have grown increasingly important in 
recent years, both in academic research and in the markets we refer to as the new Life 
Markets, i.e., the capital markets that trade longevity-linked assets and liabilities. 
Mortality improvements around the world are putting more and more pressure on 
governments, pension funds, life insurance companies as well as individuals, to deal with 
the longevity risk they face. At the same time, capital markets can, in principle, provide 
vehicles to hedge longevity risk effectively and transfer the risk from those unwilling or 
unable to handle it to those willing to speculate in such risk for increased returns or who 
have a counterpoising risk that longevity risk can hedge, e.g., life insurance.  Many new 
investment products have been created both by the insurance/reinsurance industry and by 
the capital markets. Mortality catastrophe bonds are an example of a successful 
insurance-linked security. Some new innovative capital market solutions for transferring 
longevity risk include longevity (or survivor) bonds, longevity (or survivor) swaps and 
mortality (or q-) forward contracts. The aim of the International Longevity Risk and 
Capital Markets Solutions Conferences is to bring together academics and practitioners 
from all over the world to discuss and analyze these exciting new developments.  
The conferences have followed closely the developments in the market. The first 
conference (Longevity One) was held at Cass Business School in London in February 
2005. This conference was prompted by the announcement of the Swiss Re mortality 
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catastrophe bond in December 2003 and the European Investment Bank/BNP 
Paribas/PartnerRe longevity bond in November 2004.  
The second conference was held in April 2006 in Chicago and hosted by the Katie School 
at Illinois State University.1
The third conference was held in Taipei, Taiwan on 20-21 July 2007. It was hosted by 
National Chengchi University.
 Since Longevity One, there have been further issues of 
mortality catastrophe bonds, as well as the release of the Credit Suisse Longevity Index. 
In the UK, new life companies backed by global investment banks and private equity 
firms were setting up for the express purpose of buying out the defined benefit pension 
liabilities of UK corporations. Goldman Sachs announced it was setting up such a buy-
out company itself (Rothesay Life) because the issue of pension liabilities was beginning 
to impede its mergers and acquisitions activities. It decided that the best way of dealing 
with pension liabilities was to remove them altogether from the balance sheets of 
takeover targets. So there was now firm evidence that a new global market in longevity 
risk transference had been established. However, as with many other economic activities, 
not all progress follows a smooth path. The EIB/BNP/PartnerRe longevity bond did not 
attract sufficient investor interest and was withdrawn in late 2005. A great deal, however, 
was learned from this failed issue about the conditions and requirements needed to launch 
a successful capital market instrument.  
2  It was decided to hold Longevity Three in the Far East, 
not only to reflect the growing importance of Asia in the global economy, but also in 
recognition of the fact that population ageing and longevity risk are problems that affect 
all parts of the world and that what we need is a global approach to solving these 
problems.3
Since the Taiwan conference, there were further developments in the capital markets. In 
December 2007, Goldman Sachs launched a monthly index suitable for trading life 
settlements.
 Since the Chicago conference, there had been many new developments, 
including: the release of the LifeMetrics Indices covering England & Wales, the US, 
Holland and Germany in March 2007 by J.P. Morgan, the Pensions Institute and Towers 
Watson (www.lifemetrics.com); the world's first publicly announced longevity swap 
between Swiss Re and the UK life office Friends' Provident in April 2007 (although this 
was structured as an insurance contract or indemnification rather than a capital market 
transaction). 
4
                                                 
1 The conference proceedings for Longevity Two were published in the December 2006 issue of the Journal 
of Risk and Insurance. 
 The index, QxX.LS, was based on a pool of 46,290 anonymized US lives 
over the age of 65 from a database of life policy sellers assessed by the medical 
underwriter AVS. In 2008, Institutional Life Services (ILS) and Institutional Life 
Administration (ILA), a life settlements trading platform and clearing house, were 
launched by Goldman Sachs, Genworth Financial, and National Financial Partners. 
2 The conference proceedings for Longevity Three were published in the Fall 2008 issue of the Asia-Pacific 
Journal of Risk and Insurance. 
3 In fact, Asia has the world’s largest and fastest growing ageing population (United Nations, 2007). 
4 Life settlements are traded life policies. In April 2007, the Institutional Life Markets Association started 
in New York, as the dedicated institutional trade body for the life settlements industry. 
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ILS/ILA was designed to modernize dealing in life settlements and meet the needs of 
consumers (by ensuring permanent anonymity of the insured) and of the capital markets 
(by providing a central clearing house for onward distribution of life settlement assets, 
whether individually or in structured form).5
 
 
Xpect Age and Cohort Indices were launched in March 2008 by Deutsche Börse. These 
indices cover, respectively, life expectancy at different ages and survival rates for given 
cohorts of lives in Germany and its regions, Holland and England & Wales.  
 
The world’s first capital market derivative transaction, a q-forward contract6
 
 between J. 
P. Morgan and the UK pension fund buy-out company Lucida, took place in January 
2008. The world’s first capital market longevity swap was executed in July 2008. Canada 
Life hedged £500m of its UK-based annuity book (purchased from the defunct UK life 
insurer Equitable Life). This was a 40-year swap customized to the insurer’s longevity 
exposure to 125,000 annuitants. The longevity risk was fully transferred to investors, 
which included hedge funds and insurance-linked securities (ILS) funds. J. P. Morgan 
acted as the intermediary and assumes counter-party credit risk. There have been nine 
publicly announced longevity swaps in the UK since the beginning of 2008, covering five 
insurance companies’ annuity books, three private sector pension funds and one local 
authority pension fund. The largest to date, covering £3bn of pension liabilities, was the 
longevity swap for the BMW (UK) Operations Pension Scheme, arranged by Deutsche 
Bank and Paternoster in February 2010, and involving a number of reinsurers, including 
Hannover Re, Pacific Life Re and Partner Re.  The most recent swap to date, announced 
in February 2011, was between the Pall (UK) Pension Fund and J. P. Morgan: this was 
innovative in being the world’s first swap to hedge the longevity risk of non-retired 
pension plan members. In February 2010, Mercer launched a pension buyout index for 
the UK to track the cost charged by insurance companies to buy out corporate pension 
liabilities: at the time of launch, the cost was some 44% higher than the accounting value 
of the liabilities which highlighted the attraction of using cheaper alternatives, such as 
longevity swaps. 
The fourth conference was held in Amsterdam on 25-26 September 2008. It was hosted 
by Netspar and the Pensions Institute.7
 
 In 2008, Credit Suisse initiated a longevity swap 
with Centurion Fund Managers, whereby Centurion acquired a portfolio of synthetic (i.e., 
simulated) life policies, based on a longevity index built by Credit Suisse. In 2009, 
survivor swaps began to be offered to the market based on Deutsche Börse’s Xpect 
Cohort Indices.  
The fifth conference was held in New York on 25-26 September 2009.8
                                                 
5 In 2010, National Financial Partners became the sole owner of ILS/ILA. 
 On 1 February 
2010, the Life and Longevity Markets Association (LLMA) was established in London 
6 Coughlan et al. (2007). 
7 The conference proceedings for Longevity Four were published in the February 2010 issue of Insurance: 
Mathematics and Economics. 
8 The conference proceedings for Longevity Five were published in the North American Actuarial Journal 
(Volume 15, Number 2, 2011). 
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by AXA, Deutsche Bank, J. P. Morgan, Legal & General, Pension Corporation, RBS and 
Swiss Re. The original members were later joined by Morgan Stanley, UBS, Aviva and Munich 
Re. LLMA was formed to promote the development of a liquid market in longevity- and 
mortality-related risks. This market is related to the insurance-linked securities (ILS) 
market and is also similar to other markets with trend risks, e.g., the market in inflation-
linked securities and derivatives. LLMA aims to support the development of consistent 
standards, methodologies and benchmarks to help build a liquid trading market needed to 
support the future demand for longevity protection by insurers and pension funds. In 
April 2011, the LifeMetrics indices were transferred to LLMA with the aim of 
establishing a global benchmark for trading longevity and mortality risk. 
 
In December 2010, building on its successful mortality catastrophe bonds and taking into 
account the lessons learned from the EIB bond, Swiss Re launched a series of eight-year 
longevity-based ILS notes valued at $50 million. To do this, it used a special purpose 
vehicle, Kortis Capital, based in the Cayman Islands. As with the mortality bonds, the 
longevity notes are designed to hedge Swiss Re's own exposure to longevity risk.  
In January 2011, the Irish government issued bonds that allow the creation of sovereign 
annuities. This followed a request from the Irish Association of Pension Funds and the 
Society of Actuaries in Ireland. If the bonds are purchased by Irish pension funds, this 
will have a beneficial effect on the way in which the Irish funding standard values 
pension liabilities. 
In April 2011, the International Society of Life Settlement Professionals (ISLSP)9
At the same time as these practical developments in the capital markets were taking 
place, academics were continuing to make progress on theoretical developments, building 
on the original idea of using longevity bonds to hedge longevity risk in the capital 
markets (Blake and Burrows, 2001). These included: 
 formed 
a life settlement and derivatives committee and announced that it was developing a life 
settlement index. The purpose of the index is to benchmark net asset values in life 
settlements trading. Investors need a reliable benchmark to measure performance and the 
index will help turn US life insurance policies into a tradable asset class according to 
ISLSP. The calculation agent for the index is AA Partners. 
• Design and pricing of longevity bonds and other longevity-linked products (e.g., 
Blake et al. (2006), Bauer (2006), Bauer and Ruβ (2006), Denuit et al. (2007), 
Barbarin (2008), Bauer et al. (2010), Chen and Cummins (2010), Kogure and 
Kurachi (2010), Dowd et al. (2011a), and Mayhew and Smith (2011)). 
• Design and pricing of longevity-linked derivatives, such as survivor swaps (e.g., 
Dowd et al., 2006), survivor forwards and swaptions (e.g., Dawson et al., 2010), 
q-forwards (e.g., Deng et. al., 2010) and mortality options (e.g., Milevsky and 
Promislow, 2001) 
• Longevity indices (e.g., Denuit (2009)) 
                                                 
9 islsp.org 
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• Securitization of longevity risk (e.g., Cowley and Cummins (2005), Lin and Cox 
(2005), Dahl (2004), Cox and Lin (2007), Biffis and Blake (2010), Wills and 
Sherris (2010), and Tsai et al. (2010)) 
• Hedging of longevity risk (e.g., Dahl and Møller (2006), Friedberg and Webb 
(2007), Wang et al. (2009), Tsai et al. (2010), Coughlan et al. (2011), Li and 
Hardy (2011), and Tzeng et al. (2011) 
• Mortality modelling and mortality term structure10
• Improvements in the analysis and design of longevity-linked retail products (e.g., 
Deng et. al., (2011), Gong and Webb (2010), Stevens at al. (2010), and Richter 
and Weber (2011)). 
 modelling (e.g., Brouhns et al. 
(2002), Cairns et al. (2006, 2008a,b, 2009), Renshaw and  Haberman (2006), 
Blake et al. (2008), Hari et al. (2008), Biffis et al. (2009), Jarner and Kryger 
(2009), Plat (2009), Brockett et. al. (2010), Cox et al. (2010), Dowd et al. (2010), 
Yang et al. (2010), D’Amato et al. (2011), Dowd et al. (2011b), Hanewald (2011)  
and Milidonis et al. (2011)) 
 
It was also becoming clear that policy makers needed to have a greater understanding of 
the developments in the new Life Markets. This is because there is an important role for 
governments to play in helping these markets grow, namely by issuing longevity bonds. 
As argued in Blake et al. (2010), government-issued longevity bonds would allow 
longevity risk to be shared efficiently and fairly between generations. In exchange for 
paying a longevity risk premium, the current generation of retirees could look to future 
generations to hedge their aggregate longevity risk. There would also be wider social 
benefits. Longevity bonds would lead to a more secure pension savings market – both 
defined contribution and defined benefit – together with a more efficient and hence more 
generous annuity market resulting in less means-tested benefits and a higher tax take. The 
new Life Markets could get help to increase market participation through the 
establishment of reliable longevity indices and key price points on the mortality term 
structure and could build on this term structure with liquid longevity derivatives. There is 
increasing global support for government-issued longevity bonds (e.g., the UK Pension 
Commission (2005, p. 229), International Monetary Fund (2006), Antolin and 
Blommestein (2007), and World Economic Forum (2009)). 
 
As mentioned before, not all paths to progress are smooth. In recent years, this has been 
particularly true in currently the largest market dealing with micro-longevity risk, namely 
life settlements.11
                                                 
10 The mortality term structure is the two-dimensional surface showing projected mortality rates at different 
ages for different future years. 
 The life settlements market has been dogged by systematic 
underestimates of policy holders’ life expectancies by certain medical underwriters, 
issues concerning premium financing, frauds, and ethical issues associated with 
‘profiting’ from individuals dying and policies maturing. In December 2009, Goldman 
11 The market for micro-longevity risk trades assets involving a small number of lives. In the case of life 
settlements, for example, the products involve individual lives and hence are subject to a significant degree 
of idiosyncratic mortality risk. This contrasts with the market for macro-longevity risk which deals with 
pension plans and annuity books and hence involves a large number of lives: here idiosyncratic mortality 
risk is much less important than aggregate mortality risk which is essentially the trend risk of getting life 
expectancy projections wrong. 
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Sachs announced it was closing down its QxX.LS index. This was partly because of the 
reputational issues associated with life settlements, but mainly because of insufficient 
commercial activity in the index. While the ethical issues are no different in substance 
from those relating to the macro-longevity market (see, e.g., Blake and Harrison, 2008), 
the micro-longevity market needs to learn some important lessons from the macro-
longevity market. The macro-longevity market has been very successful at promoting 
good basic research on the analysis of the stochastic mortality forecasting models it uses 
and putting these models into the public domain and has also been much more transparent 
with the data it uses. This suggests a way forward for the life settlements micro-longevity 
market.  
 
As with the previous conferences, Longevity Six consisted of both academic papers and 
more practical and policy-oriented presentations. The conference location in Sydney was 
motivated by the fact that, while Australians are successfully accumulating funds for 
retirement, there is a negligible annuity market in Australia, implying that Australians 
will be seriously exposed to longevity risk when they retire. The conference was 
addressed, among others, by the following keynote speakers: 
• Guy Coughlan, Managing Director and Global Head of LifeMetrics and Pension 
Solutions, J.P. Morgan:  “The Life & Longevity Markets Association: The 
Development of a Longevity and Mortality Trading Market”  and “The Role of 
Longevity Indices in Longevity Hedging: A Framework for Evaluating Basis Risk 
and Hedge Effectiveness” 
• Morton Lane (Lane Financial Chicago): “Longevity Risk from the Perspective of 
the ILS Markets”  
• Ross Jones (Member and Deputy Chairman of APRA, President of the 
International Organisation of Pension Supervisors, Deputy Chairman of the 
OECD Working Party on Private Pensions): “Longevity Risk: Public and Private 
Sector Solutions and the Government’s Role”  
• Martin Clarke (Executive Director of Financial Risk, Pension Protection Fund, 
UK): “Longevity Risk Transfer: A PPF Perspective”  
• David Blake (Professor of Pensions Economic and Director of the Pensions 
Institute, Cass Business School): “Sharing Longevity Risk: Why Governments 
should issue Longevity Bonds” 
• Marco Flores (Managing Director, Credit Suisse, London): “Developments and 
Structuring in Longevity Markets” 
• Michael Crane (Coventry Capital): “Longevity Risk and Life Settlements”. 
The academic papers that were selected by us as the editors of this Special Issue went 
through a refereeing process subject to the usual high standards of Geneva Papers. They 
cover the following themes:  longevity risk, the valuation of mortality-linked securities, 
mortality modelling, securitization in the reverse mortgage market, hedging longevity and 
financial risk in life insurance companies and incidence experience in life insurance 
companies. We briefly discuss each of the 10 papers selected.   
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In ‘Longevity Risk from the Perspective of the ILS Markets’, Morton Lane reflects on the 
development of the risk transfer vehicles that are beginning to appear in the longevity 
market and to contrast them with the experience of risk transfer in the natural catastrophe 
market. The natural catastrophe market has used nontraditional vehicles – catastrophe (or 
cat) bonds, a form of insurance-linked security – for more than 15 years, arguably starting 
as far back as 1992 after Hurricane Andrew. The longevity market is newer, in that ILS-
like longevity risk transfer only began some three years ago. The concept of transferring 
longevity risk has been around somewhat longer but early experiments did not meet with 
immediate success. The paper answers the question: in what ways are these two markets 
different and what lessons can one market learn from the other? 
 
In ‘Longevity Risk in Fair Valuing Level-Three Assets in Securitized Portfolios’, Peter 
M. Mazonas, P.J. Eric Stallard, and Lynford Graham argue that fair value accounting 
aims to establish a three-level hierarchy that distinguishes (1) readily observable 
measurement inputs from (2) less readily observable measurement inputs and (3) 
unobservable measurement inputs. Level 3 longevity valued assets will pose unique 
valuation risks once securitized pools of these alternative asset classes come to market as 
investment vehicles for pension plans and individual retirement accounts. No uniform 
framework is available to assure consistent fair market valuation and transparency for 
investor decision-making. Applying existing international auditing standards and 
analytical procedures (IFRS 13) will offer a platform upon which fund managers, their 
auditors, and actuaries can agree upon uniform valuation and presentation guidelines. 
Application of these quasi-governmental standards will bring future liquidity to otherwise 
illiquid capital market instruments. This paper presents a valuation methodology 
consistent with fair value accounting and auditing standards. The methodology 
incorporates longevity predictive modeling in a form that is compatible with Bayes factor 
weighted average valuation techniques. The methodology is applicable to fair valuation 
of life settlement portfolios where the combination of too few large death benefit policies 
and large variances in individual life expectancy estimates currently challenge accurate 
valuation and periodic re-valuation. 
 
In ‘Economic Pricing of Mortality-Linked Securities in the Presence of Population Basis 
Risk’, Johnny Siu-Hang Li, Rui Zhou and Ken Seng Tan argue that standardized 
mortality-linked securities are easier to analyze and more conductive to the development 
of liquidity. However, when a pension plan relies on standardized instruments to hedge 
its longevity risk exposure, it is inevitably subject to various forms of basis risk. In this 
paper, the authors use an economic pricing method to study the impact of population 
basis risk, that is, the risk due to the mismatch in the populations of the exposure and the 
hedge, on prices of mortality-linked securities. The pricing method considered is highly 
transparent, allowing us to understand how population basis risk affects the demand and 
supply of a mortality-linked security. The authors apply the method to a hypothetical 
longevity bond, using real mortality data from different populations. Illustrations show 
that, interestingly, population basis risk can affect the price of a mortality-linked security 
in different directions, depending on the properties of the populations involved. 
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In ‘Applications of Forward Mortality Factor Models in Life Insurance Practice’, Nan 
Zhu and Daniel Bauer argue that two of the most important challenges for the application 
of stochastic mortality models in life insurance practice are their complexity and their 
apparent incompatibility with classical life contingencies theory, which provides the 
backbone of insurers’ electronic data processing systems. Forward mortality factor 
models comprise one model class that overcomes these challenges. Relying on a simple 
model version that originates from a semi-parametric estimation based on British 
population mortality data, the paper demonstrates the merits of this model class by 
discussing several practically important example applications. In particular, the authors 
calculate the economic capital for a stylized life insurer, present a closed-form solution 
for the value of a guaranteed annuity option, and derive the fair option fee for a 
guaranteed minimum income benefit within a variable annuity contract. The numerical 
results illustrate the economic significance of systematic mortality risk. 
 
In ‘Modelling Mortality with Common Stochastic Long-Run Trends’, Séverine Gaille 
and Michael Sherris argue that modelling mortality and longevity risk is critical to 
assessing risk for insurers issuing longevity risk products. It has challenged practitioners 
and academics alike because of first the existence of common stochastic trends and 
second the unpredictability of an eventual mortality improvement in some age-groups. 
When considering cause-of-death-mortality rates, both aforementioned trends are 
additionally affected by the cause of death. Longevity trends are usually forecasted using 
a Lee-Carter model with a single stochastic time series for period improvements, or using 
an age-based parametric model with univariate time series for the parameters. This study 
assesses a multivariate time series model for the parameters of the Heligman-Pollard 
function, through vector error correction models which include the common stochastic 
long-run trends. The model is applied to circulatory disease deaths in USA over a 50 year 
period and is shown to be an improvement over both the Lee-Carter model and the 
stochastic parameter ARIMA Heligman-Pollard model. 
 
In ‘A Quantitative Comparison of the Lee-Carter Model under Different Types of Non-
Gaussian Innovations’, Chou-Wen Wang, Hong-Chih Huang and I-Chien Liu remind us 
that in the classical Lee-Carter model, the mortality indices that are assumed to be a 
random walk model with drift are normally distributed. However, for long-term mortality 
data, the error terms of the Lee-Carter model and the mortality indices have tails thicker 
than those of a normal distribution and appear to be skewed. This study examines five 
non-Gaussian distributions – Student’s t-distribution and its skew extension (i.e., 
generalized hyperbolic skew Student’s t-distribution), one finite-activity Lévy model 
(jump diffusion distribution), and two infinite activity or pure jump models (variance 
gamma and normal inverse Gaussian) – to model the error terms of the Lee-Carter model. 
With mortality data from six countries over the period 1900–2007, both in-sample model 
selection criteria (e.g., Bayesian information criterion, Kolmogorov-Smirnov test, 
Anderson-Darling test, Cramér-von-Mises test) and out-of-sample projection errors 
indicate a preference for modeling the Lee-Carter model with non-Gaussian innovations. 
 
In ‘Securitization and Tranching Longevity and House Price Risk for Reverse Mortgage 
Products’, Sharon Yang recognizes that reverse mortgage products are growing 
increasingly popular in many developed countries. The paper designs a tranching security 
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to deal with longevity and house price risks for reverse mortgage products. The 
securitization structure for reverse mortgage products, the collateralized reverse mortgage 
obligation (CRMO), is similar to that for the collateralized debt obligation (CDO). 
However, unlike the CDO, the CRMO takes into account the dynamics of future 
mortality rates and house price returns instead of the default rate. To capture longevity 
risk for reverse mortgage borrowers, this study employ the Cairns-Blake-Dowd model to 
project future mortality rates, as well as compares these results with those from the Lee-
Carter model and a static mortality table. The house price return dynamics are modeled 
using an ARMA-GARCH process. The calculation of fair spreads of CRMO in different 
tranches is illustrated under the risk-neutral valuation framework. On the basis of 
mortality experience and the program of Home Equity Conversion Mortgage in the 
United States, this study demonstrates the problems of using static mortality tables and 
models risk for pricing fair spreads for CRMO numerically. 
 
In ‘Securitization of Crossover Risk in Reverse Mortgages’, Hong-Chih Huang, Chou-
Wen Wang and Yuan-Chi Miao show that when the outstanding balance exceeds the 
housing value before the loan is settled, the insurer suffers an exposure to crossover risk 
induced by three risk factors: interest rates, house prices and mortality rates. Taking into 
account housing price risk, interest rate risk and longevity risk, the paper presents a three-
dimensional lattice method that simultaneously captures the evolution of housing prices 
and short-term interest rates in order to calculate the fair valuation of reverse mortgages 
numerically. For a reverse mortgage insurer, the premium structure of reverse mortgage 
insurance is determined by setting the present value of the total expected claim losses 
equal to the present value of the premium charges. However, when the actual loss is 
higher than the expected loss, the insurer will incur an unexpected loss. To offset the 
potential loss, the authors design two types of crossover bonds to transfer the unexpected 
loss to bond investors. Hence, through the crossover bonds, reverse mortgage insurers 
can partly transfer crossover risk onto bond holders. 
 
In ‘Using Reserve Mortgages to Hedge Longevity and Financial Risks for Life Insurers: 
A Generalized Immunization Approach’, Jennifer Wang, Ming-hua Hsieh and Yu-fen 
Chiu argue that the launch of new innovative longevity-linked products, such as reverse 
mortgages, increases the complexity and challenges faced by insurers in implementing an asset-
liability management strategy. With house price dynamics to account for and a large final 
payment received at the end of the policy year, a reverse mortgage provides a different liability 
duration pattern from an annuity. The authors propose a generalized immunization approach for 
obtaining the optimal product portfolio that will hedge the longevity and financial risks of life 
insurance companies. The proposed approach does not rely on specific assumptions about 
mortality or interest rate models. As long as the scenarios generated by the adopted models are 
highly correlated, the proposed approach should be effective. By using stochastic mortality and 
interest rate models and Monte Carlo simulations, the authors show that the proposed generalized 
immunization approach can serve as an effective vehicle for controlling the aggregate risk of life 
insurance companies. The numerical results further demonstrate that adding reverse mortgages to 
the insurers’ product portfolio creates better hedge effectiveness and reduces total surplus risk.  
 
Finally, Jack C. Yue and Hong-Chih Huang in ‘A Study of Incidence Experience for 
Taiwan Life Insurance’ argue that mortality improvement has become a major issue in 
ratemaking for insurance companies and that ratemaking is especially difficult in Taiwan. 
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Two reasons contribute to the difficulty: one is the population size and the other is the 
rapid improvement in mortality. Because the history of life insurance in Taiwan is 
relatively short, all life insurance products are typically based on the same experience life 
table which is constructed from the population purchasing all types of insurance products 
in Taiwan. In this study, the authors use experience data from Taiwan life insurance 
companies to explore whether there are risk factors related to the mortality rates. Further, 
the experience data are also used to evaluate whether the customers of life insurance 
companies possess mortality patterns similar to that of the overall population in Taiwan. 
 
We would like to express our sincere gratitude to all the referees and also to Samantha 
Solida for her editorial support during the preparation of this volume. Most of all, we 
would like to thank the authors for their fine contributions. 
 
Longevity Seven took place in Frankfurt on 8-9 September 2011. The Journal of Risk and 
Insurance will publish a Special Issue of selected papers presented at this conference. 
Longevity Eight will take place in Waterloo, Canada on 7-8 September 2012 and 
Longevity Nine will take place in Beijing in 2013. 
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